Direct-to-Patient Clinical Supply Services: Amid the surge in remote clinical studies, the imperative of facilitating direct-to-patient distribution of clinical supplies has gained utmost importance for clinical sponsors. Renejix’s RxReach® Direct-to-Patient (DTP) services enable the seamless delivery of clinical supplies straight to patients’ homes, significantly reducing or even obviating the need for on-site clinical visits.
Similar Posts
Analytical Method Optimization Based on Quality by Design
Quality by Design (QbD) is a well-known pharmaceutical industry strategy for enhancing production processes, including active pharmaceutical ingredients and medicinal products. Companies…
Small Molecule Analytical Services
This document provides both a high-level overview of Renejix’s stand-alone small molecule analytical services, and a detailed list of services organized by…
Early Phase Development Using Integrated Solutions
A newly formed pharmaceutical company was creating a novel cardiometabolic drug, a new small molecule, that was in Phase 2a testing in…
Precision Formulation via Small Batch Optimization
It is typical to encounter a restricted number of APIs during the initial stages of drug development. This limitation hinders the swift…
Equipment Lists
Please check out the below links to access our list of equipments available at the respective locations1. Hauppauge, New York2. Islip, New…
FormaDose™ Design: Solution For Dosage Form Selection
FormaDose® Design Solution is a comprehensive drug design assessment consisting of a holistic review of the molecule, patient, and market considerations. Led…